Iron deficiency and red cell indices in patients with heart failure

被引:58
作者
Tkaczyszyn, Michal [1 ,2 ]
Comin-Colet, Josep [3 ,4 ]
Voors, Adriaan A. [5 ]
van Veldhuisen, Dirk J. [5 ]
Enjuanes, Cristina [3 ,4 ]
Moliner-Borja, Pedro [3 ,4 ]
Rozentryt, Piotr [6 ]
Polonski, Lech [6 ]
Banasiak, Waldemar [2 ]
Ponikowski, Piotr [2 ,7 ]
van der Meer, Peter [5 ]
Jankowska, Ewa A. [1 ,2 ]
机构
[1] Wroclaw Med Univ, Dept Heart Dis, Lab Appl Res Cardiovasc Syst, Wroclaw, Poland
[2] Mil Hosp, Ctr Heart Dis, Cardiol Dept, Wroclaw, Poland
[3] Hosp del Mar, IMIM, Med Res Inst, Heart Dis Biomed Res Grp,Program Res Inflammatory, Barcelona, Spain
[4] Univ Autonoma Barcelona, Dept Med, Barcelona, Spain
[5] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands
[6] Med Univ Silesia, Div Dent Zabrze, Sch Med, Silesian Ctr Heart Dis Zabrze,Dept Cardiol 3, Katowice, Poland
[7] Wroclaw Med Univ, Dept Heart Dis, Wroclaw, Poland
关键词
Heart failure; Iron deficiency; Anaemia; Red cell indices; Complete blood count; INTRAVENOUS IRON; FERRIC CARBOXYMALTOSE; EXERCISE CAPACITY; ANEMIA; DIAGNOSIS; PREVALENCE; ETIOLOGY; THERAPY; DESIGN;
D O I
10.1002/ejhf.820
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims To investigate the prevalence of iron deficiency (ID) in heart failure (HF) patients with normal vs. abnormal red cell indices (RCI), the associations between iron parameters and RCI, and prognostic consequences of ID independently of RCI. Methods and results We analysed clinical data of 1821 patients with HF [mean age 66 13 years; 71% men; New York Heart Association class I/II/III/IV (11%/39%/44%/6%); left ventricular ejection fraction >45%: 19%]. Iron deficiency (ferritin <100 mu g/L or ferritin 100-299 mu g/L with transferrin saturation <20%) was common irrespective of the presence of anaemia (haemoglobin <12 g/dL in women and <13 g/dL in men) or low RCI, from 75% in anaemic subjects with low mean corpuscular volume (MCV), mean corpuscular haemoglobin (MCH), and MCH concentration (MCHC), to 36% in non-anaemic subjects with MCV, MCH, and MCHC above the lower limit of normal. After adjustment for clinical variables, iron parameters remained independently associated with haemoglobin, MCV, MCH, MCHC, mean reticulocyte haemoglobin content (CHR), and red cell distribution width (RDW). In multivariable Cox proportional hazard regression models there was a trend towards higher mortality in patients with vs. without ID when adjusted for relevant HF prognosticators and MCH or MCHC (but not haemoglobin, CHR or RDW). Conclusions Patients with HF should be routinely screened for ID irrespective of the presence of anaemia or abnormal RCI. The detrimental impact of ID on long-term survival in HF is partially independent of RCI.
引用
收藏
页码:114 / 122
页数:9
相关论文
共 39 条
  • [11] Quality counts: new parameters in blood cell counting
    Briggs, C.
    Mellors, I.
    Roderick, A.
    Ward, A.
    O'Malley, C.
    Barker, J.
    De La Salle, B.
    McTaggart, P.
    Hyde, K.
    Machin, S. J.
    [J]. INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2009, 31 (03) : 277 - 297
  • [12] Iron and erythropoiesis: a dual relationship
    Camaschella, Clara
    Pagani, Alessia
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 93 (01) : 21 - 26
  • [13] PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE
    COCKCROFT, DW
    GAULT, MH
    [J]. NEPHRON, 1976, 16 (01) : 31 - 41
  • [14] Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status
    Comin-Colet, Josep
    Enjuanes, Cristina
    Gonzalez, Gina
    Torrens, Ainhoa
    Cladellas, Merce
    Merono, Oona
    Ribas, Nuria
    Ruiz, Sonia
    Gomez, Miquel
    Maria Verdu, Jose
    Bruguera, Jordi
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2013, 15 (10) : 1164 - 1172
  • [15] Heart failure programmes in countries with a primary care-based health care system. Are additional trials necessary? Design of the DEAL-HF study
    de la Porte, PWFBA
    Lok, DJA
    van Wijngaarden, J
    Cornel, JH
    Pruijsers-Lamers, D
    van Veldhuisen, DJ
    Hoes, AW
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2005, 7 (05) : 910 - 920
  • [16] Detection, evaluation, and management of iron-restricted erythropoiesis
    Goodnough, Lawrence Tim
    Nemeth, Elizabeta
    Ganz, Tomas
    [J]. BLOOD, 2010, 116 (23) : 4754 - 4761
  • [17] Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: a meta-analysis of randomized controlled trials
    Jankowska, Ewa A.
    Tkaczyszyn, Michal
    Suchocki, Tomasz
    Drozd, Marcin
    von Haehling, Stephan
    Doehner, Wolfram
    Banasiak, Waldemar
    Filippatos, Gerasimos
    Anker, Stefan D.
    Ponikowski, Piotr
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 (07) : 786 - 795
  • [18] Iron deficiency defined as depleted iron stores accompanied by unmet cellular iron requirements identifies patients at the highest risk of death after an episode of acute heart failure
    Jankowska, Ewa A.
    Kasztura, Monika
    Sokolski, Mateusz
    Bronisz, Marek
    Nawrocka, Sylwia
    Oleskowska-Florek, Weronika
    Zymlinski, Robert
    Biegus, Jan
    Siwolowski, Pawel
    Banasiak, Waldemar
    Anker, Stefan D.
    Filippatos, Gerasimos
    Cleland, John G. F.
    Ponikowski, Piotr
    [J]. EUROPEAN HEART JOURNAL, 2014, 35 (36) : 2468 - +
  • [19] Iron status in patients with chronic heart failure
    Jankowska, Ewa A.
    Malyszko, Jolanta
    Ardehali, Hossein
    Koc-Zorawska, Ewa
    Banasiak, Waldemar
    von Haehling, Stephan
    Macdougall, Iain C.
    Weiss, Guenter
    McMurray, John J. V.
    Anker, Stefan D.
    Gheorghiade, Mihai
    Ponikowski, Piotr
    [J]. EUROPEAN HEART JOURNAL, 2013, 34 (11) : 827 - 834
  • [20] Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives
    Jankowska, Ewa A.
    von Haehling, Stephan
    Anker, Stefan D.
    Macdougall, Iain C.
    Ponikowski, Piotr
    [J]. EUROPEAN HEART JOURNAL, 2013, 34 (11) : 816 - 826